Improved Inventory Management
In the biopharma industry, inventory management is complicated by the fact that manufacturers do not have visibility into the post or pre-manufacturing supply chain and, as we provide lifesaving medications, there is a necessity to ensure that there is a sufficient supply to serve our patients. In some cases, there may also be a regulatory …
ADLT™ and Getting a handle on API Inventory
Recently, I spoke to a Pharma Company and asked them how much visibility they had into the manufacturing of APIs and other raw ingredients. The representative responded: “We don’t have any visibility into the API’s”. As with the rest of the supply chain, this lack of visibility has a significant impact on inventory levels and …
ADLT™: Creating Inventory Visibility – 4 Reasons Pharma Hangs On To Inventory So Long
The use of Advanced Digital Ledger Technology™ (ADLT™), of which the Blockchain is an example, can have a tremendous impact on improving the flow of information across the entire supply chain. It empowers biopharmaceutical manufacturers as they now have direct access to supply chain and patient level data without using third party vendors. But …